COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer
Segal, N., Tie, J., Kopetz, S., Ducreux, M., Chen, E., Dienstmann, R.,…Tabernero, J. (2024b). COLUMBIA-1: a randomised study of durvalumab … Read More